Maowei Yang

Dr. Maowei Yang

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2020 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
HMHongdong Ma
Hongdong Ma
XWXindong Wang
Xindong Wang
WZWeilin Zhang
Weilin Zhang
HLHaitian Li
Haitian Li
WZWei Zhao
Wei Zhao
MYMaowei Yang
Maowei Yang
Ferroptosis is recently identified, an iron- and reactive oxygen species- (ROS-) dependent form of regulated cell death. This study was designed to determine the existence of ferroptosis in the pathogenesis of type 2 diabetic osteoporosis and confirm that melatonin can inhibit the ferroptosis of osteoblasts through activating Nrf2/HO-1 signaling pathway to improve bone microstructure in vivo and in vitro. We treated MC3T3-E1 cells with different concentrations of melatonin (1, 10, or 100μM) and exposed them to high glucose (25.5mM) for 48h in vitro. Our data showed that high glucose can induce osteoblast cytotoxicity and the accumulation of lipid peroxide, the mitochondria of osteoblast show the same morphology changes as the erastin treatment group, and the expression of ferroptosis-related proteins glutathione peroxidase 4 (GPX4) and cystine-glutamate antiporter (SLC7A11) is downregulated, but these effects were reversed by ferroptosis inhibitor ferrastatin-1 and iron chelator deferoxamine (DFO). Furthermore, western blot and real-time polymerase chain reaction were used to detect the expression levels of nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1); osteogenic capacity was evaluated by alizarin red S staining and the expression of osteoprotegerin, osteocalcin, and alkaline phosphatase; the results showed that the expression levels of these proteins in osteoblasts with 1, 10, or 100μM melatonins were significantly higher than the high glucose group, but after using Nrf2-SiRNA interference, the therapeutic effect of melatonin was significantly inhibited. We also performed in vivo experiments in a diabetic rat model treated with two concentrations of melatonin (10, 50mg/kg). Dynamic bone histomorphometry and micro-CT were used to observe the rat bone microstructure, and the expression of GPX4 and Nrf2 was determined by immunohistochemistry. Here, we first report that high glucose induces ferroptosis via increased ROS/lipid peroxidation/glutathione depletion in type 2 diabetic osteoporosis. More importantly, melatonin significantly reduced the level of ferroptosis and improved the osteogenic capacity of MC3T3-E1 through activating the Nrf2/HO-1 pathway in vivo and in vitro.

16 February 2021 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
XWXinDong Wang
XinDong Wang
HMHongDong Ma
HongDong Ma
JSJun Sun
Jun Sun
TZTianYu Zheng
TianYu Zheng
PZPeng Zhao
Peng Zhao
MYMaowei Yang
Maowei Yang

1 January 2011 in Phytomedicine
Verified
Journal Article
Closed access
MYMaowei Yang
Maowei Yang
TWTong-Hao Wang
Tong-Hao Wang
PYPei-Pei Yan
Pei-Pei Yan
LCLi-Wei Chu
Li-Wei Chu
JYJiang Yu
Jiang Yu
BGBao-Lei Guo
Bao-Lei Guo

1 November 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
HMHong-Zheng Meng
Hong-Zheng Meng
WZWei-Lin Zhang
Wei-Lin Zhang
FLFei Liu
Fei Liu
MYMaowei Yang
Maowei Yang
The interaction between advanced glycation end products (AGEs) and receptor of AGEs (RAGE) is associated with the development and progression of diabetes-associated osteoporosis, but the mechanisms involved are still poorly understood. In this study, we found that AGE-modified bovine serum albumin (AGE-BSA) induced a biphasic effect on the viability of hFOB1.19 cells; cell proliferation was stimulated after exposure to low dose AGE-BSA, but cell apoptosis was stimulated after exposure to high dose AGE-BSA. The low dose AGE-BSA facilitates proliferation of hFOB1.19 cells by concomitantly promoting autophagy, RAGE production, and the Raf/MEK/ERK signaling pathway activation. Furthermore, we investigated the effects of AGE-BSA on the function of hFOB1.19 cells. Interestingly, the results suggest that the short term effects of low dose AGE-BSA increase osteogenic function and decrease osteoclastogenic function, which are likely mediated by autophagy and the RAGE/Raf/MEK/ERK signal pathway. In contrast, with increased treatment time, the opposite effects were observed. Collectively, AGE-BSA had a biphasic effect on the viability of hFOB1.19 cells in vitro, which was determined by the concentration of AGE-BSA and treatment time. A low concentration of AGE-BSA activated the Raf/MEK/ERK signal pathway through the interaction with RAGE, induced autophagy, and regulated the proliferation and function of hFOB1.19 cells.

21 March 2012 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
DLDan Liang
Dan Liang
MYMaowei Yang
Maowei Yang
BGBaolei Guo
Baolei Guo
JCJunjun Cao
Junjun Cao
LYLei Yang
Lei Yang
ZGZhida Gao
Zhida Gao

12 November 2011 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
DLDan Liang
Dan Liang
MYMaowei Yang
Maowei Yang
BGBaolei Guo
Baolei Guo
JCJunjun Cao
Junjun Cao
LYLei Yang
Lei Yang
XGXiaoDong Guo
XiaoDong Guo